Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

Read more

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Contact Us

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

Read more

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Follow Us On Linkedin

Menarini Stories

By marking #BPDCNday, Menarini Group is giving a rare and aggressive blood cancer nowhere to hide
Categories
menarini-com:blog/en/post-category/our-health
menarini-com:blog/en/post-category/menarini-news

Together, we make a difference

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare hematologic malignancy that often manifests with skin lesions.

Although BPDCN is mostly diagnosed in elderly patients, it may occur at any age,1,2 with men three times more likely to be affected than women. There are roughly 700 cases in the United States and 1000 in Europe.3

BPDCN not only presents as skin lesions but also has a hematologic component. Its similarity to other blood cancers has contributed to its frequent misdiagnoses and very poor prognosis. This highlights the urgent need to raise awareness of the disease to ensure proper diagnosis and better outcomes for patients.

People need to know about BPDCN.

We at Menarini Group are proud to actively support Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Disease Awareness Day (#BPDCNday) as part of our unwavering commitment to make a difference in the lives of patients with cancer.



People with BPDCN need early diagnosis

So what can we do to improve the situation for patients with BPDCN?

Speeding up diagnosis may be a very important weapon when we are fighting back against BPDCN.

The diagnosis and care of BPDCN is a joint effort between dermatologists, pathologists, and hematologist-oncologists. By working together, they can avert potential misdiagnoses.

Recently, a specific protein (CD123) was identified as a way to diagnose BPDCN.* The date 1/23—the 1st month and 23rd day of the year is aimed to strengthen the key role of CD123 for a correct BPDCN diagnosis.

 

Menarini Group commits to raising awareness of BPDCN

With #BPDCNday, our aim is to raise awareness in the medical community and unite patients and healthcare professionals in the fight against this disease. We hope you will join us in supporting patients and families affected by BPDCN around the world.

We at Menarini Group believe that working together can make real changes. We also know that the medical professionals and patients dealing with BPDCN are committed to the fight against BPDCN.

 

Learn more about BPDCN at: www.bpdcninfo.com

Watch our YouTube channel

 

*BPDCN can include other markers, such as TCL1, TCF4, and CD303 (BDCA2).4,5

 

References

  1. Facchetti F et al. Mod Pathol. 2016 Feb;29(2):98-111.
  2. Sapienza MR et al. Haematologica. 2019 Apr;104(4):729-737.
  3. Sullivan JM, Rizzieri DA. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):16-23.
  4. Pagano L et al. Br J Haematol. 2016 Jul;174(2):188-202.
  5. Ceribelli M et al. Cancer Cell. 2016 Nov 14;30(5):764-778.

Fraud Warning Disclaimer

Please be aware that certain individuals might approach you by falsely presenting themselves as our employees, affiliates, agents or representatives. Under this false pretense, they might try to gain access to your personal information or to acquire money or other valuables from you by offering fictitious employment opportunities or by claiming that they are contacting you on our behalf. The contacting individual or organisation may, for example, claim that we can guarantee your employment if you pay them a certain amount of money. Such fraudulent offers and claims are usually received via email, the internet, text message, phone, etc. These claims and offers are fraudulent and invalid and you are strongly advised to exercise great caution when you receive such an offer of employment or notice. Be very mindful of such scams.Below we list some of the features such an offer or claim may have:

Below we list some of the features such an offer or claim may have:

• It may propose a phone or instant message program interview and/or money as a precondition for hiring You may be requested to disclose private, sensitive or confidential information

• You may be told that you were contacted in such a manner because it is a matter of urgency

Such an offer or claim will probably be in the form of an email sent from a fake email address or from a free email address and not from an official Menarini Group email address. Please take extra caution while examining such an email address, as the perpetrators may misspell an official Menarini Group email address and use a slightly modified version of an official Menarini Group email address.

Please note that you will never receive a fraudulent employment offer or any other similar claim from us, because we do not provide any recruitment services. Moreover, we will never ask you for money in exchange for employment opportunities or other similar services. Any such offer of employment or any other service in exchange for fees that claims to be from us is deceitful and part of a fraud.

Criminal and/or civil liabilities may arise from such actions and we intend to cooperate with competent law enforcement agencies. Accordingly, we would ask you to immediately get in touch with us upon receiving a suspicious offer or claim and additionally notify the police or other competent authority.

In any case, please disregard any written or oral request related to a job offer or an interview that you believe is or might be fraudulent or suspicious.

Please note that under no circumstances shall Menarini Group be held liable or responsible for any claims, losses, damages, expenses or other inconvenience resulting from or in any way connected to the actions of these imposters.

Fake Job Awareness

Fake job advertisements are increasingly appearing on the internet and social media. Please be aware of employment scams where people or entities misuse Menarini or Stemline's names to post fake job advertisements.

Stemline will only extend an offer with an interview process and will never charge any money for joining our company. All our current job openings are displayed on the Careers section of our Menarini website, accessible here: https://www.menarini.com/en-us/careers/careers-in-oncology

How to protect against a fake job scam:

  • Never pay for anything in response to a job application or offer.
  • If you receive an offer for a job, you did not apply for, it is fake.
  • A job offer without a personal interview or interaction is a scam.
  • Menarini or Stemline never post jobs on Facebook; if you see one, it is a scam.
  • Watch out for badly written emails or emails not coming from an official Menarini or Stemline company domain.
  • Always check the official company Menarini-Stemline website to ensure that the job exists.
  • Listen to your instincts; if you suspect a scam, it probably is.